All Online

1 - 5 of 5 results

Refine

Active filters

Migraine
1.5 CME CREDITS

What do primary care providers need to know about acute head issues? Join expert faculty as they review important questions they get asked about these topics!


1 CME CREDIT

What do primary care providers need to know about migraine, movement disorders, dizziness, and vertigo? Join neurologists Patricia Greenstein, Daniel Press, and Rashmi Halker Singh as they review important questions they get asked about these topics!


1 CME CREDIT

What do primary care providers need to know about migraine, CKD, and deprescribing? Join neurologist Rashmi Halker Singh, nephrologist Rajeev Raghavan, and geriatrician Lee Lindquist as they review important questions they get asked about these topics!


Speaker on virtual set
2 CME CREDITS

Migraine: A Patient-centered Approach to Diagnosis and Treatment

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

2.00 CME

How does your management of patients with migraine compare to the experts? By participating in this six-part educational initiative, which incorporates a comprehensive roundtable faculty discussion, augmented reality, and a patient narrative, you will be able to incorporate key information into your clinical practice immediately.


jeopardy logo
0.25 CME CREDIT

Answers and Advances in Acute Migraine Treatment

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

All migraine patients need acute migraine treatment. And yet, approximately 50% of patients remain undertreated primarily owing to the adverse effect profiles of older, non-targeted treatments, or because of contraindications to triptans. New targeted drug classes are now available for acute migraine treatment, including oral small-molecule CGRP antagonists (gepants) and selective serotonin antagonists (ditans). These new migraine-specific acute treatment options provide an effective means of improving adherence and reducing migraine-related disability and socioeconomic burden.